Digital lifestyle program plus an AI chat helper to improve blood sugar in people with type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional trial compares access to a digital Lifestyle tool coupled with a large language model (LLM) versus randomized controls over one year to measure changes in long-term metabolic control. Participants interact with expert-written lifestyle content and an LLM that prompts self-reflection and recommends relevant texts from the tool. Key eligibility includes adults aged 35 or older with type 2 diabetes, internet access, and the ability to read and write Swedish, while people treated with insulin or with recent medication changes are excluded. The primary outcome is change in glycemic control over 12 months at a single clinical research center in Malmö, Sweden.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with type 2 diabetes
* Diagnosis of diabetes mellitus was based on prior documentation or treatment with anti-hyperglycemic medication
* age at or above 35 years
* access to Internet
* informed consent

Exclusion Criteria:

* Treatment with insulin
* Change of anti-diabetic treatment with three months prior to inclusion
* Participation in other study that may affect the outcomes
* Condition or treatment that in the judgement of the Investigator precludes participation
* Inability to read and write in Swedish
* Work in competing areas

Where it's running

• Clinical Research Center
  Malmö, Skåne County, Sweden Recruiting

Study contacts

• Principal investigator: Anders Rosengren, MD PhD — Region Skane
• Study coordinator: Birgitta Abrahamsson
• Email: birgitta.x.abrahamsson@skane.se
• Phone: +46705316704

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Proliverenol for liver fat and insulin resistance in type 2 diabetes

  This study tests whether adding Proliverenol to standard diabetes care can improve liver fat and blood sugar control in adults with type 2 diabetes.

  Recruiting Phase 2 Universitas Sriwijaya · Palembang, South Sumatera · NCT07928661

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Safety test of NNC9836-0001 in adults with overweight/obesity or type 2 diabetes

  This study tests whether the new medicine NNC9836-0001 is safe and tolerable in adults who are overweight or have type 2 diabetes, compared to placebo.

  Recruiting Phase 1 Novo Nordisk A/S · Neuss · NCT07896109

• RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes

  This study tests the accuracy and safety of the RIGHTEST iFree 2 continuous glucose monitor in pregnant adults with type 1, type 2, or gestational diabetes.

  Recruiting Bionime Corporation · Ulm, Baden-Wurttemberg · NCT07889388

• EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes

  This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.

  Recruiting Phase 3 Eli Lilly and Company · Tucson, Arizona and 74 other locations · NCT07881458

• Maridebart cafraglutide vs. semaglutide for type 2 diabetes on metformin

  This trial tests whether maridebart cafraglutlide is as good as semaglutide at improving blood sugar in adults with type 2 diabetes who take metformin (with or without an SGLT-2 inhibitor).

  Recruiting at 8 sites Phase 3 Amgen · San Diego, California and 7 other locations · NCT07866066

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.